# Cocoa Exercise Performance Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/cocoa-exercise-performance-meta-analysis-evidence-review
Category: evidence-review
Summary: Cocoa Exercise Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass ar
Last reviewed: 2026-08-12
Reviewed by: Migaku Evidence Review
# Cocoa Exercise Performance Meta-analysis: What the Evidence Says

## Quick Answer

Cocoa Exercise Performance Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Response of VO 2max to dark chocolate consumption in healthy subjects: A systematic review and meta‐analysis of randomized controlled trials | systematic review | 1 | 2025-02-25 | 10.14814/phy2.70256 |
| Physiological and Recovery Responses to Dietary Polyphenols in the Context of Exercise: Relevance for Muscle Aging and Sarcopenia | narrative review | 3 | 2026-02-27 | 10.3390/nu18050788 |

## What The Sources Report

- Studies have indicated that higher levels of aerobic capacity are associated with improved athletic performance and a reduced risk of cardiovascular diseases, as well as lower mortality rates in non-athletes (McKendry et al., ). [Mehdipour Aref (2025); evidence level 1]
- Overall, enhancing aerobic capacity can contribute to improved quality of life and better public health (Blair et al., ; Kodama et al., ; Lee et al., ). [Mehdipour Aref (2025); evidence level 1]
- Growing evidence indicates that these bioactive compounds can modulate intracellular signaling pathways and induce adaptive cellular responses, including mechanisms consistent with mitohormesis, thereby enhancing cellular stress resistance and metabolic flexibility. [Fazekas-Pongor Vince (2026); evidence level 3]
- This overlap raises the possibility that factors influencing recovery responses may have relevance for aging muscle, although direct clinical evidence supporting this translational link is still limited. [Fazekas-Pongor Vince (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For cocoa exercise performance meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Mehdipour Aref (2025). Response of VO 2max to dark chocolate consumption in healthy subjects: A systematic review and meta‐analysis of randomized controlled trials. DOI: 10.14814/phy2.70256. PMCID: PMC11859664. PMID: 40000922. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC11859664/
- Fazekas-Pongor Vince (2026). Physiological and Recovery Responses to Dietary Polyphenols in the Context of Exercise: Relevance for Muscle Aging and Sarcopenia. DOI: 10.3390/nu18050788. PMCID: PMC12987180. PMID: 41829959. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12987180/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.